{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T23:06:38Z","timestamp":1777417598431,"version":"3.51.4"},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"3_suppl","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,10,1]]},"abstract":"<jats:sec>\n                  <jats:title>Background:<\/jats:title>\n                  <jats:p>Sodium nitroprusside is the preferred agent for the treatment of high blood pressure during acute aortic syndrome if blood pressure remains elevated after heart rate control with beta-blockers. The increasing cost of sodium nitroprusside in the USA led us to assess the efficacy and safety of intravenous clevidipine, a calcium channel blocker with quick onset of action, short half-life and significantly lower costs than sodium nitroprusside, in patients presenting with acute aortic syndrome.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods:<\/jats:title>\n                  <jats:p>We performed a retrospective chart review of consecutive patients admitted to the Cleveland Clinic Cardiac Intensive Care Unit from 2013\u20132016 with a diagnosis of acute aortic syndrome. Patients who received intravenous sodium nitroprusside were compared with those receiving intravenous clevidipine. The primary outcome was a significant difference in blood pressure at one, three and six hours. Secondary outcomes included time to achieving blood pressure target and in hospital mortality with rates of hypotension and bradycardia as safety endpoints.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results:<\/jats:title>\n                  <jats:p>A total of 85 patients with suspected acute aortic pathology received clevidipine and 50 received sodium nitroprusside. Clinical and demographic characteristics were similar in both groups, except for a higher incidence of abdominal aortic aneurysm in the clevidipine group and for a trend towards higher use of labetalol in the clevidipine group. There were no significant differences in blood pressure or heart rate at one, three and six hours after starting either infusion. The rates of hypotension, bradycardia and in-hospital mortality did not differ. Time to achieve blood pressure control were also similar between groups.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion:<\/jats:title>\n                  <jats:p>Intravenous clevidipine appears to be a safe and effective alternative to sodium nitroprusside for the management of high blood pressure during acute aortic dissection. In the USA, clevidipine could represent a cost effective therapy providing similar outcomes than sodium nitroprusside.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1177\/2048872618777919","type":"journal-article","created":{"date-parts":[[2018,6,7]],"date-time":"2018-06-07T14:55:11Z","timestamp":1528383311000},"page":"S5-S12","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":11,"title":["Clevidipine as a therapeutic and cost-effective alternative to sodium nitroprusside in patients with acute aortic syndromes"],"prefix":"10.1093","volume":"9","author":[{"given":"Carlos L","family":"Alviar","sequence":"first","affiliation":[{"name":"Heart and Vascular Institute, Cleveland Clinic Foundation, USA"},{"name":"Division of Cardiovascular Medicine, University of Florida, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandra","family":"Gutierrez","sequence":"additional","affiliation":[{"name":"Heart and Vascular Institute, Cleveland Clinic Foundation, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leslie","family":"Cho","sequence":"additional","affiliation":[{"name":"Heart and Vascular Institute, Cleveland Clinic Foundation, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amar","family":"Krishnaswamy","sequence":"additional","affiliation":[{"name":"Heart and Vascular Institute, Cleveland Clinic Foundation, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amr","family":"Saleh","sequence":"additional","affiliation":[{"name":"Heart and Vascular Institute, Cleveland Clinic Foundation, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael A","family":"Lincoff","sequence":"additional","affiliation":[{"name":"Heart and Vascular Institute, Cleveland Clinic Foundation, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Roselli","sequence":"additional","affiliation":[{"name":"Heart and Vascular Institute, Cleveland Clinic Foundation, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Militello","sequence":"additional","affiliation":[{"name":"Heart and Vascular Institute, Cleveland Clinic Foundation, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Venu","family":"Menon","sequence":"additional","affiliation":[{"name":"Heart and Vascular Institute, Cleveland Clinic Foundation, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2020,10,1]]},"reference":[{"key":"2021020117045438000_bibr1-2048872618777919","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/nrcardio.2014.203","article-title":"Management of acute aortic syndrome","volume":"12","author":"Clough","year":"2015","journal-title":"Nat Rev Cardiol"},{"key":"2021020117045438000_bibr2-2048872618777919","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.bpa.2016.07.001","article-title":"Acute aortic syndrome: A systems approach to a time-critical disease","volume":"30","author":"Kawabori","year":"2016","journal-title":"Best Pract Res Clin Anaesthesiol"},{"key":"2021020117045438000_bibr3-2048872618777919","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1001\/jama.283.7.897","article-title":"The International Registry of Acute Aortic Dissection (IRAD): New insights into an old disease","volume":"283","author":"Hagan","year":"2000","journal-title":"JAMA"},{"key":"2021020117045438000_bibr4-2048872618777919","doi-asserted-by":"crossref","first-page":"E43","DOI":"10.1002\/ccd.22537","article-title":"2010 ACCF\/AHA\/AATS\/ACR\/ASA\/SCA\/SCAI\/SIR\/STS\/SVM guidelines for the diagnosis and management of patients with thoracic aortic disease: Executive summary. A report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine","volume":"76","author":"Hiratzka","year":"2010","journal-title":"Catheter Cardiovasc Interv"},{"key":"2021020117045438000_bibr5-2048872618777919","doi-asserted-by":"crossref","first-page":"3802","DOI":"10.1161\/CIRCULATIONAHA.105.534198","article-title":"Acute aortic syndromes","volume":"112","author":"Tsai","year":"2005","journal-title":"Circulation"},{"key":"2021020117045438000_bibr6-2048872618777919","doi-asserted-by":"crossref","first-page":"462","DOI":"10.4103\/0970-9185.142799","article-title":"Sodium nitroprusside in 2014: A clinical concepts review","volume":"30","author":"Hottinger","year":"2014","journal-title":"J Anaesthesiol Clin Pharmacol"},{"key":"2021020117045438000_bibr7-2048872618777919","first-page":"387","article-title":"Current practices in general medicine. 7. Treatment of hypertensive emergencies including use of sodium nitroprusside","volume":"34","author":"Gifford","year":"1959","journal-title":"Proc Staff Meet Mayo Clin"},{"key":"2021020117045438000_bibr8-2048872618777919","first-page":"CD003653","article-title":"Pharmacological interventions for hypertensive emergencies","volume":"1","author":"Perez","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"2021020117045438000_bibr9-2048872618777919","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1093\/bja\/42.10.859","article-title":"Sodium nitroprusside as a hypotensive agent in general anaesthesia","volume":"42","author":"Taylor","year":"1970","journal-title":"Br J Anaesth"},{"key":"2021020117045438000_bibr10-2048872618777919","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1378\/chest.06-2490","article-title":"Hypertensive crises: Challenges and management","volume":"131","author":"Marik","year":"2007","journal-title":"Chest"},{"key":"2021020117045438000_bibr11-2048872618777919","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1161\/01.CIR.11.2.188","article-title":"Cardiovascular actions of sodium nitroprusside in animals and hypertensive patients","volume":"11","author":"Page","year":"1955","journal-title":"Circulation"},{"key":"2021020117045438000_bibr12-2048872618777919","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00004311-197816020-00003","article-title":"Sodium nitroprusside: Metabolism and general considerations","volume":"16","author":"Ivankovich","year":"1978","journal-title":"Int Anesthesiol Clin"},{"key":"2021020117045438000_bibr13-2048872618777919","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/00004311-197816020-00004","article-title":"Sodium nitroprusside and cardiovascular hemodynamics","volume":"16","author":"Miletich","year":"1978","journal-title":"Int Anesthesiol Clin"},{"key":"2021020117045438000_bibr14-2048872618777919","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jacc.2008.02.083","article-title":"Sodium nitroprusside for advanced low-output heart failure","volume":"52","author":"Mullens","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"2021020117045438000_bibr15-2048872618777919","first-page":"38","article-title":"When the price of the blood-pressure drug Nitropress leaped from $215 to $881 last year, an increase of 310%, it triggered public outrage: What\u2019s behind the gouging?","volume":"187","author":"Edwards","year":"2016","journal-title":"Time"},{"key":"2021020117045438000_bibr16-2048872618777919","unstructured":"Rockoff\n              JD and Silverman E\n            \n          \n          Pharmaceutical companies buy rivals\u2019 drugs, then jack up the prices. Wall Street Journal. Available at: https:\/\/www.wsj.com\/articles\/pharmaceutical-companies-buy-rivals-drugs-then-jack-up-the-prices-1430096431 (accessed 2 June 2018)."},{"key":"2021020117045438000_bibr17-2048872618777919","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1111\/j.1540-8191.2006.00213.x","article-title":"Managing emergency hypertension in aortic dissection and aortic aneurysm surgery","volume":"21","author":"Khoynezhad","year":"2006","journal-title":"J Card Surg"},{"key":"2021020117045438000_bibr18-2048872618777919","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1007\/s40265-014-0313-6","article-title":"Clevidipine: A review of its use for managing blood pressure in perioperative and intensive care settings","volume":"74","author":"Keating","year":"2014","journal-title":"Drugs"},{"key":"2021020117045438000_bibr19-2048872618777919","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.2165\/00003495-200666130-00010","article-title":"Intravenous nicardipine: Its use in the short-term treatment of hypertension and various other indications","volume":"66","author":"Curran","year":"2006","journal-title":"Drugs"},{"key":"2021020117045438000_bibr20-2048872618777919","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1046\/j.1365-2125.1999.00933.x","article-title":"Clinical and pharmacokinetic results with a new ultrashort-acting calcium antagonist, clevidipine, following gradually increasing intravenous doses to healthy volunteers","volume":"47","author":"Ericsson","year":"1999","journal-title":"Br J Clin Pharmacol"},{"key":"2021020117045438000_bibr21-2048872618777919","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s002280050594","article-title":"Pharmacokinetics and pharmacodynamics of clevidipine in healthy volunteers after intravenous infusion","volume":"55","author":"Ericsson","year":"1999","journal-title":"Eur J Clin Pharmacol"},{"key":"2021020117045438000_bibr22-2048872618777919","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/ajh\/hps009","article-title":"Efficacy and safety of dual calcium channel blockade for the treatment of hypertension: A meta-analysis","volume":"26","author":"Alviar","year":"2013","journal-title":"Am J Hypertens"},{"key":"2021020117045438000_bibr23-2048872618777919","doi-asserted-by":"crossref","first-page":"A875","DOI":"10.1016\/S0735-1097(15)60875-0","article-title":"Comparative safety of intravenous nicardipine infusion in patients with and without systolic dysfunction","volume":"65","author":"Alviar","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2021020117045438000_bibr24-2048872618777919","first-page":"635","article-title":"Therapeutic interchange of clevidipine for sodium nitroprusside in cardiac surgery","volume":"41","author":"Cruz","year":"2016","journal-title":"PT"},{"key":"2021020117045438000_bibr25-2048872618777919","article-title":"Navigating pharmaceutical price increases: A strategy to protect appropriate use, reduce waste, and identify therapeutic alternatives","author":"Khot","year":"2017","journal-title":"New England Journal of Medicine Catalyst"},{"key":"2021020117045438000_bibr26-2048872618777919","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/BF03256583","article-title":"Clevidipine: A review of its use in the management of acute hypertension","volume":"9","author":"Deeks","year":"2009","journal-title":"Am J Cardiovasc Drugs"},{"key":"2021020117045438000_bibr27-2048872618777919","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1034\/j.1399-6576.2000.440210.x","article-title":"Coronary and systemic hemodynamic effects of clevidipine, an ultra-short-acting calcium antagonist, for treatment of hypertension after coronary artery surgery","volume":"44","author":"Kieler-Jensen","year":"2000","journal-title":"Acta Anaesthesiol Scand"},{"key":"2021020117045438000_bibr28-2048872618777919","unstructured":"http:\/\/reference.medscape.com\/drug\/cleviprex-clevidipine-342405."},{"key":"2021020117045438000_bibr29-2048872618777919","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1056\/NEJMc1700244","article-title":"Nitroprusside and isoproterenol use after major price increases","volume":"377","author":"Khot","year":"2017","journal-title":"N Engl J Med"},{"key":"2021020117045438000_bibr30-2048872618777919","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1213\/01.ane.0000281443.13712.b9","article-title":"Clevidipine effectively and rapidly controls blood pressure preoperatively in cardiac surgery patients: The results of the randomized, placebo-controlled efficacy study of clevidipine assessing its preoperative antihypertensive effect in cardiac surgery-1","volume":"105","author":"Levy","year":"2007","journal-title":"Anesth Analg"},{"key":"2021020117045438000_bibr31-2048872618777919","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1213\/ane.0b013e3181732e53","article-title":"Treatment of acute postoperative hypertension in cardiac surgery patients: An Efficacy Study of Clevidipine Assessing its Postoperative Antihypertensive Effect in Cardiac Surgery-2 (ESCAPE-2), a randomized, double-blind, placebo-controlled trial","volume":"107","author":"Singla","year":"2008","journal-title":"Anesth Analg"},{"key":"2021020117045438000_bibr32-2048872618777919","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1213\/ane.0b013e31818240db","article-title":"The ECLIPSE trials: Comparative studies of clevidipine to nitroglycerin, sodium nitroprusside, and nicardipine for acute hypertension treatment in cardiac surgery patients","volume":"107","author":"Aronson","year":"2008","journal-title":"Anesth Analg"},{"key":"2021020117045438000_bibr33-2048872618777919","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1097\/00003643-200309000-00004","article-title":"Comparison of clevidipine with sodium nitroprusside in the control of blood pressure after coronary artery surgery","volume":"20","author":"Powroznyk","year":"2003","journal-title":"Eur J Anaesthesiol"},{"key":"2021020117045438000_bibr34-2048872618777919","doi-asserted-by":"crossref","first-page":"e0150625","DOI":"10.1371\/journal.pone.0150625","article-title":"Evidence Anesthesia Review Group. Perioperative use of clevidipine: A systematic review and meta-analysis","volume":"11","author":"Espinosa","year":"2016","journal-title":"PLoS One"},{"key":"2021020117045438000_bibr35-2048872618777919","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1097\/00000542-200205000-00010","article-title":"Clevidipine in adult cardiac surgical patients: A dose-finding study","volume":"96","author":"Bailey","year":"2002","journal-title":"Anesthesiology"},{"key":"2021020117045438000_bibr36-2048872618777919","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1590\/0004-282X20150104","article-title":"Sodium nitroprusside: Low price and safe drug to control BP during thrombolysis in AIS","volume":"73","author":"Koslyk","year":"2015","journal-title":"Arq Neuropsiquiatr"}],"container-title":["European Heart Journal. Acute Cardiovascular Care"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/2048872618777919","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/2048872618777919","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/ehjacc\/article-pdf\/9\/3_suppl\/S5\/36165674\/ehjacc00s5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ehjacc\/article-pdf\/9\/3_suppl\/S5\/36165674\/ehjacc00s5.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,20]],"date-time":"2021-04-20T00:19:16Z","timestamp":1618877956000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjacc\/article\/9\/3_suppl\/S5-S12\/6125554"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,1]]},"references-count":36,"journal-issue":{"issue":"3_suppl","published-online":{"date-parts":[[2020,10,1]]},"published-print":{"date-parts":[[2020,10,1]]}},"URL":"https:\/\/doi.org\/10.1177\/2048872618777919","relation":{},"ISSN":["2048-8734","2048-8726"],"issn-type":[{"value":"2048-8734","type":"electronic"},{"value":"2048-8726","type":"print"}],"subject":[],"published-other":{"date-parts":[[2020,10,1]]},"published":{"date-parts":[[2020,10,1]]}}}